Wealthfront Advisers’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $394K | Buy |
4,128
+438
| +12% | +$42K | ﹤0.01% | 929 |
|
|
2026
Q1 | $382K | Buy |
3,690
+575
| +18% | +$65.2K | ﹤0.01% | 891 |
|
|
2025
Q4 | $314K | Sell |
3,115
-52,866
| -94% | -$5.74M | ﹤0.01% | 915 |
|
|
2025
Q3 | $6.9M | Buy |
55,981
+27,100
| +94% | +$3.36M | 0.02% | 320 |
|
|
2025
Q2 | $3.47M | Buy |
28,881
+4,634
| +19% | +$618K | 0.01% | 449 |
|
|
2025
Q1 | $3.57M | Sell |
24,247
-802
| -3% | -$122K | 0.01% | 415 |
|
|
2024
Q4 | $4.07M | Buy |
25,049
+47
| +0.2% | +$7.69K | 0.01% | 379 |
|
|
2024
Q3 | $4.07M | Sell |
25,002
-839
| -3% | -$124K | 0.01% | 352 |
|
|
2024
Q2 | $3.53M | Sell |
25,841
-26,425
| -51% | -$3.67M | 0.01% | 355 |
|
|
2024
Q1 | $8M | Sell |
52,266
-5,708
| -10% | -$852K | 0.03% | 174 |
|
|
2023
Q4 | $8.27M | Buy |
57,974
+34,535
| +147% | +$4.6M | 0.03% | 153 |
|
|
2023
Q3 | $3.07M | Sell |
23,439
-35,891
| -60% | -$5.45M | 0.01% | 327 |
|
|
2023
Q2 | $9.44M | Buy |
59,330
+4,738
| +9% | +$764K | 0.04% | 131 |
|
|
2023
Q1 | $8.64M | Buy |
54,592
+13,680
| +33% | +$2.05M | 0.04% | 133 |
|
|
2022
Q4 | $5.74M | Sell |
40,912
-9,128
| -18% | -$1.3M | 0.03% | 178 |
|
|
2022
Q3 | $6.42M | Sell |
50,040
-7,558
| -13% | -$1.09M | 0.03% | 143 |
|
|
2022
Q2 | $8.12M | Buy |
57,598
+18,777
| +48% | +$2.68M | 0.04% | 119 |
|
|
2022
Q1 | $5.4M | Buy |
38,821
+14,595
| +60% | +$2.24M | 0.02% | 197 |
|
|
2021
Q4 | $4.22M | Buy |
24,226
+3,752
| +18% | +$625K | 0.02% | 220 |
|
|
2021
Q3 | $3.39M | Buy |
20,474
+5,517
| +37% | +$950K | 0.02% | 223 |
|
|
2021
Q2 | $2.69M | Sell |
14,957
-905
| -6% | -$165K | 0.01% | 246 |
|
|
2021
Q1 | $3.06M | Sell |
15,862
-4,453
| -22% | -$857K | 0.02% | 179 |
|
|
2020
Q4 | $4.1M | Buy |
20,315
+6,978
| +52% | +$1.44M | 0.02% | 112 |
|
|
2020
Q3 | $2.8M | Buy |
13,337
+423
| +3% | +$94.2K | 0.02% | 130 |
|
|
2020
Q2 | $2.83M | Buy |
12,914
+1,332
| +12% | +$266K | 0.02% | 117 |
|
|
2020
Q1 | $2.01M | Buy |
11,582
+2,838
| +32% | +$469K | 0.02% | 145 |
|
|
2019
Q4 | $1.34M | Sell |
8,744
-3,340
| -28% | -$499K | 0.01% | 264 |
|
|
2019
Q3 | $1.83M | Sell |
12,084
-2,215
| -15% | -$350K | 0.02% | 185 |
|
|
2019
Q2 | $2.19M | Buy |
14,299
+3,218
| +29% | +$492K | 0.02% | 143 |
|
|
2019
Q1 | $1.78M | Buy |
11,081
+700
| +7% | +$109K | 0.02% | 169 |
|
|
2018
Q4 | $1.6M | Buy |
+10,381
| New | +$1.62M | 0.02% | 160 |
|
Other funds holding CLX
CIM
EIC
Wealthfront Advisers's CLX Position: Q2 2026 in Review
Wealthfront Advisers increased its Clorox (CLX) stake by 12% in Q2 2026, buying an estimated $42K and bringing the position to 4,128 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #929.
Wealthfront Advisers first reported a position in CLX in Q4 2018 and has held it in 31 quarters since. The position peaked at $9.44M in Q2 2023. 766 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Wealthfront Advisers held 4,128 shares of Clorox worth $394K as of Q2 2026.
- Wealthfront Advisers bought 438 Clorox shares in Q2 2026, an estimated $42K.
- Clorox made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #929 holding.
- Wealthfront Advisers first reported a position in Clorox in Q4 2018 and has held it in 31 quarters since.
- Wealthfront Advisers's Clorox position peaked at $9.44M in Q2 2023.
- 766 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.